Cytokinetics Files 2024 10-K, Details Debt and Agreements
Ticker: CYTK · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1061983
| Field | Detail |
|---|---|
| Company | Cytokinetics Inc (CYTK) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, debt, agreements, financials
TL;DR
Cytokinetics 2024 10-K is in. Debt notes, Astellas deal, and Oxford/SVB loan details are all in the filing.
AI Summary
Cytokinetics Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company's business address is 350 Oyster Point Boulevard, South San Francisco, CA 94080. Key financial elements mentioned include Convertible Senior Notes due 2027 and 2026, and various agreements like the 2016 Astellas Amendment and a Loan and Security Agreement with Oxford and Silicon Valley Bank.
Why It Matters
This filing provides investors with a comprehensive overview of Cytokinetics' financial health, including its debt obligations and significant contractual relationships, which are crucial for assessing the company's operational stability and future prospects.
Risk Assessment
Risk Level: medium — The filing details significant debt instruments and various agreements, indicating financial leverage and potential contractual risks that require careful investor consideration.
Key Numbers
- 20241231 — Fiscal Year End (Reporting period for the 10-K filing.)
- 20250227 — Filing Date (Date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- CYTOKINETICS INC (company) — Filer
- 350 OYSTER POINT BOULEVARD (location) — Business Address
- SOUTH SAN FRANCISCO (location) — Business Address City
- CA (location) — Business Address State
- 94080 (location) — Business Address Zip
- Convertible Senior Notes Due 2027 (dollar_amount) — Debt Instrument
- 2016 Astellas Amendment (company) — Agreement
- Loan and Security Agreement (company) — Agreement
- Oxford and Silicon Valley Bank (company) — Lender
- Convertible Senior Notes Due 2026 (dollar_amount) — Debt Instrument
FAQ
What is the total amount of Convertible Senior Notes due in 2027?
The filing mentions 'cytk:ConvertibleSeniorNotesDue2027Member' but does not specify the exact dollar amount in the provided text.
What is the nature of the '2016 Astellas Amendment'?
The filing references 'cytk:TwoThousandSixteenAstellasAmendmentMember' in relation to 'srt:MaximumMember' as of '2023-12-31', suggesting it's a significant amendment to an agreement with Astellas.
When was the Loan and Security Agreement with Oxford and Silicon Valley Bank entered into?
The filing indicates the 'cytk:LoanAndSecurityAgreementMember' with 'cytk:OxfordAndSiliconValleyBankMember' is associated with the date '2022-05-31'.
What type of liabilities are associated with the Convertible Senior Notes Due 2026?
The filing links 'cytk:ConvertibleSeniorNotesDue2026Member' with 'us-gaap:LiabilityMember' as of '2023-12-31'.
When did Cytokinetics issue common stock in a private placement?
The filing notes 'us-gaap:CommonStockMember' and 'us-gaap:PrivatePlacementMember' in relation to the date '2024-05-28'.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding CYTOKINETICS INC (CYTK).